These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 32226769

  • 1. Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches.
    Abbas F, El Kossi M, Shaheen IS, Sharma A, Halawa A.
    World J Transplant; 2020 Feb 28; 10(2):29-46. PubMed ID: 32226769
    [Abstract] [Full Text] [Related]

  • 2. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 28; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 3. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, Omar H, Martino R, Halkes C, Faraci M, Theunissen K, Kalwak K, Hubacek P, Sica S, Nozzoli C, Fagioli F, Matthes S, Diaz MA, Migliavacca M, Balduzzi A, Tomaszewska A, Camara Rde L, van Biezen A, Hoek J, Iacobelli S, Einsele H, Cesaro S, Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Clin Infect Dis; 2013 Sep 28; 57(6):794-802. PubMed ID: 23771985
    [Abstract] [Full Text] [Related]

  • 4. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.
    Styczynski J, Einsele H, Gil L, Ljungman P.
    Transpl Infect Dis; 2009 Oct 28; 11(5):383-92. PubMed ID: 19558376
    [Abstract] [Full Text] [Related]

  • 5. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
    Lim WH, Russ GR, Coates PT.
    Nephrology (Carlton); 2006 Aug 28; 11(4):355-66. PubMed ID: 16889577
    [Abstract] [Full Text] [Related]

  • 6. Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies.
    Gao XN, Lin J, Wang LJ, Li F, Li HH, Wang SH, Huang WR, Gao CJ, Yu L, Liu DH.
    Ann Hematol; 2019 Sep 28; 98(9):2163-2177. PubMed ID: 31243569
    [Abstract] [Full Text] [Related]

  • 7. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
    Taylor AL, Marcus R, Bradley JA.
    Crit Rev Oncol Hematol; 2005 Oct 28; 56(1):155-67. PubMed ID: 15979320
    [Abstract] [Full Text] [Related]

  • 8. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
    Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T.
    Transpl Infect Dis; 2016 Feb 28; 18(1):44-54. PubMed ID: 26574232
    [Abstract] [Full Text] [Related]

  • 9. Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation.
    Asleh R, Alnsasra H, Habermann TM, Briasoulis A, Kushwaha SS.
    Front Cardiovasc Med; 2022 Feb 28; 9():787975. PubMed ID: 35282339
    [Abstract] [Full Text] [Related]

  • 10. Post-transplant lymphoproliferative disorders.
    Singavi AK, Harrington AM, Fenske TS.
    Cancer Treat Res; 2015 Feb 28; 165():305-27. PubMed ID: 25655616
    [Abstract] [Full Text] [Related]

  • 11. Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder.
    Major A, Kamdar M.
    Curr Treat Options Oncol; 2018 May 24; 19(7):33. PubMed ID: 29797086
    [Abstract] [Full Text] [Related]

  • 12. Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell Transplantation.
    Nagle SJ, Reshef R, Tsai DE.
    Clin Chest Med; 2017 Dec 24; 38(4):771-783. PubMed ID: 29128025
    [Abstract] [Full Text] [Related]

  • 13. Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients.
    Marques HH, Shikanai-Yasuda MA, dAzevedo LS, Caiaffa-Filho HH, Pierrotti LC, Aquino MZ, Lopes MH, Maluf NZ, Campos SV, Costa SF.
    Rev Soc Bras Med Trop; 2014 Dec 24; 47(5):543-6. PubMed ID: 25467252
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, ESCMID Study Group of Infection in Compromised Hosts.
    Clin Microbiol Infect; 2014 Sep 24; 20 Suppl 7():109-18. PubMed ID: 24475976
    [Abstract] [Full Text] [Related]

  • 15. Posttransplant lymphoproliferative disorder.
    Everly MJ, Bloom RD, Tsai DE, Trofe J.
    Ann Pharmacother; 2007 Nov 24; 41(11):1850-8. PubMed ID: 17940127
    [Abstract] [Full Text] [Related]

  • 16. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB, Wang Y, Song QJ, Shen DH.
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep 24; 41(9):607-12. PubMed ID: 23157829
    [Abstract] [Full Text] [Related]

  • 17. Post-transplant lymphoproliferative disorders.
    Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S.
    Nat Rev Dis Primers; 2016 Jan 28; 2():15088. PubMed ID: 27189056
    [Abstract] [Full Text] [Related]

  • 18. Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia.
    Hotta M, Nakaya A, Fujita S, Satake A, Nakanishi T, Azuma Y, Tsubokura Y, Konishi A, Yoshimura H, Ito T, Ishii K, Nomura S.
    Hematol Rep; 2018 May 14; 10(2):7527. PubMed ID: 30046412
    [Abstract] [Full Text] [Related]

  • 19. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.
    Styczynski J, van der Velden W, Fox CP, Engelhard D, de la Camara R, Cordonnier C, Ljungman P, Sixth European Conference on Infections in Leukemia, a joint venture of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation (EBMT-IDWP), the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).
    Haematologica; 2016 Jul 14; 101(7):803-11. PubMed ID: 27365460
    [Abstract] [Full Text] [Related]

  • 20. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.
    Weinstock DM, Ambrossi GG, Brennan C, Kiehn TE, Jakubowski A.
    Bone Marrow Transplant; 2006 Mar 14; 37(6):539-46. PubMed ID: 16462755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.